Decheng Capital LLC
MENLO PARK, CA · CIK 2010850 · 13F filing filed 2025-08-13
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyAtherton, CA
$396.0m
reported value
+11.1% vs Q1 2025
25positions
92.4%in top 10
1 new
3 added
8 reduced
3 sold out
vs Q1 2025
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CG ONCOLOGY INC CGON | $165.7m41.84% | Unchanged |
| AARDVARK THERAPEUTICS INC AARD | $53.0m13.38% | Unchanged |
| NUVATION BIO INC NUVB | $50.6m12.78% | Unchanged |
| UPSTREAM BIO INC UPB | $36.1m9.11% | Unchanged |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $13.9m3.52% | Unchanged |
| BEYONDSPRING INC BYSI | $10.6m2.69% | Reduced -351.2k |
| MERUS N V MRUS | $9.9m2.51% | Unchanged |
| KRYSTAL BIOTECH INC KRYS | $9.1m2.29% | Added +1.0k |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $8.6m2.16% | Added +10.0k |
| REVOLUTION MEDICINES INC RVMD | $8.3m2.10% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $5.7m1.45% | Unchanged |
| LYELL IMMUNOPHARMA INC COM | $5.3m1.33% | Reduced -1 |
| ARCELLX INC ACLX | $4.5m1.13% | Added +497.6k |
| CRINETICS PHARMACEUTICALS IN CRNX | $4.1m1.04% | Reduced -35.0k |
| AURA BIOSCIENCES INC AURA | $3.2m0.82% | Unchanged |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $1.5m0.39% | Reduced -696.4k |
| EQUILLIUM INC EQ | $1.4m0.35% | Unchanged |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $888.6k0.22% | Reduced -96.0k |
| ARCUS BIOSCIENCES INC RCUS | $811.2k0.20% | Reduced -648.8k |
| ILLUMINA INC ILMN | $761.3k0.19% | Reduced -3.8k |
| LEGEND BIOTECH CORP LEGN | $709.8k0.18% | Reduced -80.0k |
| GRAIL INC GRAL | $498.0k0.13% | Unchanged |
| PYXIS ONCOLOGY INC PYXS | $359.5k0.09% | Unchanged |
| REZOLUTE INC RZLT | $267.2k0.07% | New |
| NUVATION BIO INC NUVB.WS | $127.3k0.03% | Unchanged |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| CYTOKINETICS INC CYTK | $4.0m100.0k shares |
| BIONTECH SE BNTX | $1.8m20.0k shares |
| VERA THERAPEUTICS INC VERA | $108.0k4.5k shares |